Back to Search
Start Over
Bariatric and metabolic surgery.
- Source :
-
Minerva endocrinologica [Minerva Endocrinol] 2013 Sep; Vol. 38 (3), pp. 237-44. - Publication Year :
- 2013
-
Abstract
- In the beginning of the 21st century obesity still represents health, social and economical threat for most of economically wealthy countries worldwide. Estimated direct costs for obesity and related comorbidities treatment exceed 5% of the total health care costs both in the US and in European Union. However, in addition there are obesity-related indirect costs linked to more frequent work sickness leave, higher unemployment rates and overall lower productivity of obese patients. Surgical treatment of obesity (bariatric surgery) is the most effective long-term treatment modality for those patients suffering from higher degrees of obesity. Bariatric surgery has not only positive effects on weight loss, but is also extremely effective in improving or resolving many of obesity-related comorbidities, which have evolved rapidly into the so-called metabolic surgery. T2DM may serve as excellent example of metabolic, obesity-related comorbidity which can be treated with bariatric-metabolic procedure even without direct relation to weight loss. In such cases bariatric surgery evolves into metabolic surgery. Thus metabolic operations (namely from the malabsorptive end) deeply influence hormonal secretion especially in the proximal part of small bowel, change parametres of entero-insular axis and have positive influence on insulin secretion, sensitivity and on the entire complex of glucose tolerance. Nowadays we can witness dramatic changes in perception of T2DM from bariatric surgeons, diabetologists, and many other medical specialists. T2DM has evolved from primarily medical disease into a condition where surgeons may play a more active role in the management of the diabetic patient. However, it has to be stressed that metabolic treatment of T2DM and other metabolic disorders need multidisciplinary approach and collaboration and that surgeon should play very important role as a multidisciplinary team member, however metabolic surgery should not yet be considered as stand-alone treatment modality.
- Subjects :
- Adipose Tissue metabolism
Comorbidity
Cost of Illness
Diabetes Mellitus, Type 2 epidemiology
Diabetes Mellitus, Type 2 metabolism
Diabetes Mellitus, Type 2 surgery
Gastrointestinal Hormones metabolism
Glucose metabolism
Homeostasis
Humans
Insulin metabolism
Insulin Secretion
Interdisciplinary Communication
Intestine, Small metabolism
Intestine, Small surgery
Malabsorption Syndromes physiopathology
Models, Biological
Obesity economics
Obesity epidemiology
Obesity metabolism
Obesity physiopathology
Patient Care Team
Postgastrectomy Syndromes physiopathology
Treatment Outcome
Weight Loss
Bariatric Surgery methods
Bariatric Surgery trends
Obesity surgery
Subjects
Details
- Language :
- English
- ISSN :
- 0391-1977
- Volume :
- 38
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Minerva endocrinologica
- Publication Type :
- Academic Journal
- Accession number :
- 24126544